Anecdotal reports have suggested that memantine may improve neurologic and cognitive symptoms of individuals with the neurodegenerative disease fragile X-associated tremor/ataxia syndrome ( FXTAS ) ; however , its efficacy and safety in this population have not been assessed in a controlled trial .